• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数学模型在淋巴丝虫病传播和控制中的应用:挑战与展望。

Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.

机构信息

Vector Control Research Centre, Indira Nagar, Medical Complex, Pondicherry - 605 006, India.

出版信息

Parasit Vectors. 2008 Feb 12;1(1):2. doi: 10.1186/1756-3305-1-2.

DOI:10.1186/1756-3305-1-2
PMID:18275593
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2275317/
Abstract

BACKGROUND

Mathematical models developed for describing the dynamics of transmission, infection, disease and control of lymphatic filariasis (LF) gained momentum following the 1997 World Health Assembly resolution and the launching of the Global Programme to Eliminate Lymphatic Filariasis (GPELF) in 2000. Model applications could provide valuable inputs for making decisions while implementing large scale programmes. However these models need to be evaluated at different epidemiological settings for optimization and fine-tuning with new knowledge and understanding on infection/disease dynamics.

DISCUSSION

EPIFIL and LYMFASIM are the two mathematical simulation models currently available for lymphatic filariasis transmission and control. Both models have been used for prediction and evaluation of control programmes under research settings. Their widespread application in evaluating large-scale elimination programmes warrants validation of assumptions governing the dynamics of infection and disease in different epidemiological settings. Furthermore, the predictive power of the models for decision support can be enhanced by generating knowledge on some important issues that pose challenges and incorporating such knowledge into the models. We highlight factors related to the efficacy of the drugs of choice, their mode of action, and the possibility that drug resistance may develop; the role of vector-parasite combinations; the magnitude of transmission thresholds; host-parasite interactions and their effects on the dynamics of infection and immunity; parasite biology, and progression to LF-associated disease.

SUMMARY

The two mathematical models developed offer potential decision making tools for transmission and control of LF. In view of the goals of the GPELF, the predictive power of these models needs to be enhanced for their wide-spread application in large scale programmes. Assimilation and translation of new information into the models is a continuous process for which generation of new knowledge on a number of uncertainties is required. Particularly, a better understanding of the role of immune mechanisms in regulating infection and disease, the (direct or immune mediated) mode of action of current drugs, their effect on adult worms, their efficacy after repeated treatment, and the population genetics of drug resistance are important factors that could make the models more robust in their predictions of the impact of programmes to eliminate LF. However, if these models are to be user-friendly in the hands of programme managers (and not remain as research tools), it would be necessary to identify those factors which can be considered as the minimum necessary inputs/outputs in operational settings for easy evaluation and on-site decision making.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ef/2275317/8051f91391e1/1756-3305-1-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ef/2275317/cc436428ebde/1756-3305-1-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ef/2275317/8051f91391e1/1756-3305-1-2-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ef/2275317/cc436428ebde/1756-3305-1-2-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/13ef/2275317/8051f91391e1/1756-3305-1-2-2.jpg

背景

描述淋巴丝虫病(LF)传播、感染、疾病和控制动态的数学模型在 1997 年世界卫生大会决议和 2000 年启动全球消灭淋巴丝虫病规划(GPELF)之后得到了发展。模型应用可以为实施大规模规划提供有价值的决策依据。然而,这些模型需要在不同的流行病学环境中进行评估,以利用新的感染/疾病动态知识进行优化和微调。

讨论

EPIFIL 和 LYMFASIM 是目前用于淋巴丝虫病传播和控制的两种数学模拟模型。这两个模型都已用于研究环境下预测和评估控制规划。它们在评估大规模消除规划中的广泛应用需要验证不同流行病学环境下感染和疾病动态的假设。此外,通过生成关于一些构成挑战的重要问题的知识并将这些知识纳入模型中,可以提高模型对决策支持的预测能力。我们强调了与首选药物的疗效、作用模式以及药物耐药性可能发展的可能性、媒介-寄生虫组合的作用、传播阈值的大小、宿主-寄生虫相互作用及其对感染和免疫动态的影响、寄生虫生物学以及进展为与 LF 相关的疾病相关的因素。

总结

开发的这两个数学模型为 LF 的传播和控制提供了潜在的决策工具。鉴于 GPELF 的目标,这些模型的预测能力需要得到增强,以便在大规模规划中广泛应用。将新信息吸收和转化到模型中是一个持续的过程,需要生成关于许多不确定性的新知识。特别是,更好地了解免疫机制在调节感染和疾病中的作用、当前药物的(直接或免疫介导)作用模式、它们对成虫的影响、重复治疗后的疗效以及药物耐药性的种群遗传学,是使模型在预测消除 LF 规划的影响方面更加稳健的重要因素。然而,如果这些模型要在规划管理人员手中变得易于使用(而不是作为研究工具),则有必要确定那些可以被视为在操作环境中进行简单评估和现场决策的最低必要投入/产出的因素。

相似文献

1
Mathematical models for lymphatic filariasis transmission and control: Challenges and prospects.数学模型在淋巴丝虫病传播和控制中的应用:挑战与展望。
Parasit Vectors. 2008 Feb 12;1(1):2. doi: 10.1186/1756-3305-1-2.
2
Modelling lymphatic filariasis transmission and control: modelling frameworks, lessons learned and future directions.淋巴丝虫病传播与控制的建模:建模框架、经验教训及未来方向。
Adv Parasitol. 2015 Mar;87:249-91. doi: 10.1016/bs.apar.2014.12.005. Epub 2015 Feb 13.
3
Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.通过数学建模预测淋巴丝虫病消除计划影响的进展与挑战
Filaria J. 2006 Mar 28;5:5. doi: 10.1186/1475-2883-5-5.
4
Continental-scale, data-driven predictive assessment of eliminating the vector-borne disease, lymphatic filariasis, in sub-Saharan Africa by 2020.到2020年在撒哈拉以南非洲消除媒介传播疾病淋巴丝虫病的大陆规模、数据驱动的预测性评估。
BMC Med. 2017 Sep 27;15(1):176. doi: 10.1186/s12916-017-0933-2.
5
Bayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.用于支持消除宏观寄生虫病淋巴丝虫病管理的模拟模型的贝叶斯校准
Parasit Vectors. 2015 Oct 22;8:522. doi: 10.1186/s13071-015-1132-7.
6
Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.量化监测数据在提高淋巴丝虫病消除模型预测中的价值。
PLoS Negl Trop Dis. 2018 Oct 8;12(10):e0006674. doi: 10.1371/journal.pntd.0006674. eCollection 2018 Oct.
7
Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.主要虫媒性蠕虫病(淋巴丝虫病)消除阈值的地理和生态异质性。
BMC Biol. 2010 Mar 17;8:22. doi: 10.1186/1741-7007-8-22.
8
Lymphatic Filariasis (Elephantiasis) Elimination: A public health success and development opportunity.消除淋巴丝虫病(象皮病):公共卫生领域的一项成就与发展机遇。
Filaria J. 2003 Sep 9;2(1):13. doi: 10.1186/1475-2883-2-13.
9
Heterogeneous dynamics, robustness/fragility trade-offs, and the eradication of the macroparasitic disease, lymphatic filariasis.异质性动力学、稳健性/脆弱性权衡与宏观寄生虫病淋巴丝虫病的根除
BMC Med. 2016 Jan 28;14:14. doi: 10.1186/s12916-016-0557-y.
10
Elimination of lymphatic filariasis: do we have the drugs to complete the job?消除淋巴丝虫病:我们有完成这项工作的药物吗?
Curr Opin Infect Dis. 2010 Dec;23(6):617-20. doi: 10.1097/QCO.0b013e32833fdee5.

引用本文的文献

1
A Next-Generation Human Lymphatic Filariasis Vaccine Candidate, rHAXT, for Clinical Development.一种用于临床开发的新一代人类淋巴丝虫病候选疫苗rHAXT。
Res Sq. 2025 Jun 21:rs.3.rs-6572437. doi: 10.21203/rs.3.rs-6572437/v1.
2
Sensitivity analysis and parameters estimation for the transmission of lymphatic filariasis.淋巴丝虫病传播的敏感性分析与参数估计
Heliyon. 2023 Sep 17;9(9):e20066. doi: 10.1016/j.heliyon.2023.e20066. eCollection 2023 Sep.
3
Assessment of antigenemia among children in four hotspots of filarial endemic districts of Nepal during post-MDA surveillance.

本文引用的文献

1
Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study.加纳流行社区盘尾丝虫感染的患病率、感染强度及伊维菌素的疗效:一项两阶段流行病学研究
Lancet. 2007 Jun 16;369(9578):2021-2029. doi: 10.1016/S0140-6736(07)60942-8.
2
An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy.班氏吴策线虫因联合化疗导致潜在多药耐药性的群体遗传学分析
Parasitology. 2007 Jul;134(Pt 7):1025-40. doi: 10.1017/S0031182007002363. Epub 2007 Feb 26.
3
Transmission dynamics of lymphatic filariasis: vector-specific density dependence in the development of Wuchereria bancrofti infective larvae in mosquitoes.
在尼泊尔丝虫病流行地区四个热点地区开展大规模药物治疗(MDA)后监测期间对儿童抗原血症的评估。
Trop Med Health. 2023 Aug 24;51(1):47. doi: 10.1186/s41182-023-00538-4.
4
Lot quality assurance sampling to assess coverage and compliance following mass drug administration to eliminate lymphatic filariasis in Fiji: A methodological approach.在斐济大规模药物治疗消除淋巴丝虫病之后,采用批量药物投放质量保证抽样方法评估覆盖率和依从性:一种方法学方法。
PLoS One. 2020 Sep 18;15(9):e0238622. doi: 10.1371/journal.pone.0238622. eCollection 2020.
5
An Expanded Transmission Assessment Survey to Confirm the Interruption of Lymphatic Filariasis Transmission in Wallis and Futuna.一项扩展传播评估调查,以确认瓦利斯和富图纳阻断淋巴丝虫病传播。
Am J Trop Med Hyg. 2019 Dec;101(6):1325-1330. doi: 10.4269/ajtmh.19-0476.
6
Ecological and Socioeconomic Predictors of Transmission Assessment Survey Failure for Lymphatic Filariasis.生态和社会经济因素对丝虫病传播评估调查失败的预测。
Am J Trop Med Hyg. 2019 Jul;101(1):271-278. doi: 10.4269/ajtmh.18-0721.
7
Quantifying the value of surveillance data for improving model predictions of lymphatic filariasis elimination.量化监测数据在提高淋巴丝虫病消除模型预测中的价值。
PLoS Negl Trop Dis. 2018 Oct 8;12(10):e0006674. doi: 10.1371/journal.pntd.0006674. eCollection 2018 Oct.
8
Modeling the Parasitic Filariasis Spread by Mosquito in Periodic Environment.周期性环境中蚊虫传播的寄生性丝虫病传播模型
Comput Math Methods Med. 2017;2017:4567452. doi: 10.1155/2017/4567452. Epub 2017 Feb 8.
9
Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.利用多模型集成框架预测淋巴丝虫病传播和消除动态。
Epidemics. 2017 Mar;18:16-28. doi: 10.1016/j.epidem.2017.02.006.
10
Making Transmission Models Accessible to End-Users: The Example of TRANSFIL.让终端用户能够使用传播模型:以TRANSFIL为例。
PLoS Negl Trop Dis. 2017 Feb 2;11(2):e0005206. doi: 10.1371/journal.pntd.0005206. eCollection 2017 Feb.
淋巴丝虫病的传播动力学:班氏吴策线虫感染性幼虫在蚊子体内发育过程中的媒介特异性密度依赖性
Med Vet Entomol. 2006 Sep;20(3):261-72. doi: 10.1111/j.1365-2915.2006.00629.x.
4
Patterns in parasite epidemiology: the peak shift.寄生虫流行病学模式:峰值转移
Parasitol Today. 1998 Oct;14(10):428-34. doi: 10.1016/s0169-4758(98)01318-0.
5
Density dependence and the control of helminth parasites.密度依赖性与蠕虫寄生虫的控制
J Anim Ecol. 2006 Nov;75(6):1313-20. doi: 10.1111/j.1365-2656.2006.01154.x.
6
Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti.阿苯达唑与伊维菌素或乙胺嗪联合选择对班氏吴策线虫中阿苯达唑抗性可能传播的群体遗传学研究
Parasitology. 2006 Nov;133(Pt 5):589-601. doi: 10.1017/S003118200600076X. Epub 2006 Jul 12.
7
Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.基于模型的试验数据分析:乙胺嗪-阿苯达唑或伊维菌素-阿苯达唑联合治疗班氏吴策线虫后微丝蚴及蠕虫繁殖力损失情况
Trop Med Int Health. 2006 May;11(5):718-28. doi: 10.1111/j.1365-3156.2006.01606.x.
8
Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modelling.通过数学建模预测淋巴丝虫病消除计划影响的进展与挑战
Filaria J. 2006 Mar 28;5:5. doi: 10.1186/1475-2883-5-5.
9
Mathematical models and lymphatic filariasis control: endpoints and optimal interventions.数学模型与淋巴丝虫病防治:终点指标与优化干预措施
Trends Parasitol. 2006 May;22(5):226-33. doi: 10.1016/j.pt.2006.03.005. Epub 2006 Mar 27.
10
Effect of yearly mass drug administration with diethylcarbamazine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment.埃及使用乙胺嗪和阿苯达唑进行年度群体药物给药对班氏丝虫病的影响:一项综合评估。
Lancet. 2006 Mar 25;367(9515):992-9. doi: 10.1016/S0140-6736(06)68426-2.